首页> 外文期刊>British journal of ophthalmology >Comparison of uveal melanoma cytopathologic sample retrieval in Trans-scleral versus vitrectomyassisted transvitreal fine needle aspiration biopsy
【24h】

Comparison of uveal melanoma cytopathologic sample retrieval in Trans-scleral versus vitrectomyassisted transvitreal fine needle aspiration biopsy

机译:经巩膜和玻璃体切除术辅助的经玻璃体细针穿刺活检中葡萄膜黑色素瘤细胞病理学标本的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Background/aims Fine needle aspiration biopsy has become a standard technique to obtain material from primary uveal melanoma for diagnosis, prognostication and research. Cytopathology requires a significantly greater tissue yield for a positive diagnosis compared to other molecular tests. The purpose of this report was to compare sample retrieval for cytopathology between trans-scleral and vitrectomy-assisted transvitreal biopsy in the same tumour in patients who underwent iodine-125 brachytherapy.Results Thirty-eight patients with a median follow-up time of 2 months were included. Overall, 27 of 38 (71%) of transvitreal biopsies, and 25 of 38 (66%) of trans-scleral biopsies yielded sufficient material for cytopathologic analysis ( p=0.62). For transvitreal and trans-scleral biopsies, larger tumours were associated with significantly higher cytopathologic yield, but tumour location did not signi ficantly affect cytopathologic yield.Methods All clinical records of patients who underwent iodine-125 brachytherapy for the treatment of uveal melanoma in conjunction with pars plana vitrectomy from whom trans-scleral and vitrectomyassisted transvitreal fine needle biopsies were obtained, were reviewed. Baseline patient and tumour characteristics, biopsy sample yield for cytopathology, and surgical outcomes were reviewed.Conclusions Trans-scleral and vitrectomy-assisted transvitreal fine needle aspiration biopsy resulted in similar tissue yield for cytopathologic analysis. As molecular prognostication becomes the standard of care for obtaining patient information and directing clinical management, further investigation of biopsy techniques is warranted.
机译:背景/目的细针穿刺活检已成为从原发葡萄膜黑色素瘤中获取材料用于诊断,预后和研究的标准技术。与其他分子检测相比,细胞病理学需要更多的组织产量来进行阳性诊断。本报告的目的是比较接受碘125-近距离放射治疗的患者在同一肿瘤中经巩膜镜和玻璃体切除术辅助的玻璃体活检的细胞病理学结果。结果38例患者的平均随访时间为2个月被包括在内。总体而言,经玻璃体活检的38个中有27个(71%),经巩膜活检的38个中有25个(66%)产生了足够的材料用于细胞病理学分析(p = 0.62)。对于玻璃体活检和经巩膜活检,较大的肿瘤与较高的细胞病理学产量相关,但肿瘤的位置对细胞病理学产量没有显着影响。方法所有接受碘125近距离放射疗法治疗葡萄膜黑色素瘤并伴有碘125的患者的所有临床记录。回顾了pars平面玻璃体切除术,从中获得经巩膜和玻璃体切除术辅助的经玻璃体细针活检。回顾了基线患者和肿瘤的特征,用于细胞病理学的活检样本产量以及手术结局。随着分子预后成为获得患者信息和指导临床治疗的护理标准,有必要对活检技术进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号